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THE accurate diagnosis of rejection following pulmo-
nary or cardiac transplantation presently requires the 
histologic interpretation of transbronchial or endomyocar-
dial biopsies, respectively. Because these procedures are 
invasive, efforts have recently been directed toward find-
ing alternative methods of determining the presence of 
active rejection episodes. 
Using 2-color flow q10metry, we examined changes in 
T-lymphocyte populations in 3 pulmonary and 3 cardiac 
transplant recipients in whom FK 506 was the sole immu-
nosuppressive agent used. These patients were chosen 
because cytolytic lymphocyte therapy was not used and so 
circulating lymphocyte counts remained consistent 
throughout the posttransplant period. This allowed early 
and sequential T-cell subset analysis and comparison with 
histologic data simultaneously obtained from biopsies. 
MATERIALS AND METHODS 
Three pUlmonary transplam recipients (2 double lung and I 
heart-lung) received FK 506 as the only maintenance immuno-
suppressive agent in the posttransplant period. These patients 
were followed for 90 to 285 days during which time each patient 
underwent 4 to 6 bronchoscopies with bronchoalveolar lavage 
(BAL) and transbronchial biopsy (TBB). Three cardiac transplant 
recipients were also included. and they too. received only FK 506 
for immunosuppression. Cardiac patients were followed for 48 to 
120 days and each undeNent 4 to 7 endomyocardial biopsies 
(EM B). The diagnosis of rejection was based on accepted his-
tologic criteria for cardiac and pulmonary transplantation. Treat-
ment of rejection episodes consisted of alterations in the dosage of 
FK 506 andlor a single bolus injection of conicosteroids. 
Total cell counts and differentials were performed on BAL fluid 
and on peripheral blood (PBL) obtained at the time of lavage or 
endomyocardial biopsy. Cells (100 ilL PBL or 1 x I(}' BAL) were 
suspended in 100 JLL of phosphate-buffered !>aline with 0.11)( 
sodium azide and labeled with various combinations of fluorescein 
isothiocyanate (FITC) and phycoerythrin (PEHabeled monoclo-
nal antibodies at 4°C for 20 minutes. Red blood cells were then 
lysed using FACSlyse solution (Becton-Dickinson. Mountain 
View, CAl for 6 minutes. All cell suspensions were then centri-
fuged for 5 minutes at 500 rpm. Supernatants were discarded and 
the cells resuspended in 0.5 ml phosphate-buffered saline and 0.5 
mL \% paraformaldehyde. The following antibody combinations 
were used: Leukogate. nonspecific JgG, T/B. CD4/C[)8, TINK. 
CD4IDR. CD8IDR, T/afJ. p,o. (All antibodies were obtained 
from Becton·Dickinson. Mountain View. CA except for 'YO ob-
tained from T Cell Sciences. Cambridge. MAl. Flow cytometry 
(2-color) was performed on a FACScan <Becton-Dickinson. 
Mountain View, CAl equipped with a Conson 30 computer 
program. Student t tests for unpaired samples were used to 
analyze alterations in the various T-cell subsets during active 
rejection episodes as compared to normal or quiescent biopsies. 
There was no difference in values oborined when the diagnOSis 
was acute cellular rejection or active otiliterative bronchiOlitis so 
they were considered together as acti .. e rejection episodes. 
RESULTS 
In pulmonary transplant patients_ the proportions of 
CD8+DR + and CD4+DR + T cells Io!xpressed as a percent 
of total CD8 and CD4) obtained fr0m BAL were signifi-
cantly higher (P = .0015 and P = .00.::3. respectively) when 
there was histologic evidence of reje-':lion than were values 
obtained when the TBB was negati .. ~ or showed resolving 
rejection (Fig I). The proportion of DR + cells did not 
exceed 34% for CD4 + DR + and 21 o/c f0r CD8 + DR + subsets 
when biopsies were negative or shov.-ed resolving rejection 
while respective values were all gre~r than 43% and 40% 
during active rejection. Two of these episodes were asso-
ciated with active cytomegalovirus infections (pneumoni-
tis). The proportions ofCD8+DR+ and CD4+DR+ T cells 
obtained on these occasions were intermediate within the 
group of rejection values. Changes in the peripheral blood 
were less striking with only the propo..""l'1ion ofCD8+DR + T 
lymphocytes exhibiting significant increases during peri-
ods of active rejection (P = .038) when compared to 
negative biopsies or to pretransplanc values (Fig 2). The 
separation in individual values for tK~ CD8+DR+ subset 
was much less distinct in the PBL. 'PJe largest proportion 
of PBL CD8+DR + T lymphocytes was seen in the 2 
recipients with CMY pneumonitis .:.oincident with the 
onset of active obliterative bronchiolr.is. 
In the cardiac recipients (Fig 3), sirnilar increases in the 
proportion of CD8+ DR + T lymph~1Kes from PBL were 
associated with moderate (grade 2-3) rejection episodes (P 
= .01) when compared to values obuined at the time of 
negative or mild (grade 0-1) rejectiOCl biopsies. As with 
pulmonary transplant recipients. no ~ificant changes in 
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Ftg'. The proportion of each DRT T-cell subset obtained from 
BAL lymphocytes of pulmonary transplant recipients when trans-
brOnChial biopsy was negative or showed active rejection. The 
IT'ean value is indicated by the straight line. The number above the 
s,rnbols refers to the number of individual value points within each 
group. CMV beside the symbol refers to a measurement taken 
when CMV pneumonitis was also present. • P = .0023. rejection vs 
negative for CD4 +DR+/CD4+; "P = .0015. rejection vs negative 
tor COS'DR+/COS+. 
the proportion of CD4" DR + T cells were found in the 
peripheral blood. 
No significant changes in the proportion or number of 
T B. CD4/CD8. or TINK were found in either pulmonary 
or cardiac transplant recipients. The majority ofT cells in 
PBL and BAL were af3 receptor positive with few express-
ing the 'Yf> receptor. 
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FIg 2. The proportion of each OR" T -<:ell subset obtained from 
peripheral blood lymphocytes from pulmonary transplant recipi-
ents when transbronchiaJ biopsy was negative or showed active 
rejection. Refer to Fig 1 for explanation of straight line and CMV .• P 
= .038, rejection vs negative for COS+DR-.c08+. 
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Fig 3. The proportion of each DR + T -cell subset obtained from 
peripheral blood lymphocytes of heart transplant recipients when 
endomyocardial biopsy was negative or showed active rejection. 
The mean value is indicated by the straight line .• P = .01. rejection 
vs negative for COS'OR+/COS-. 
DISCUSSION AND CONCLUSIONS 
These 'results suggest that graft-infiltrating T lymphocytes 
(BAL) exhibit a greater degree of activation during pulmo-
nary rejection as measured by significant increases in the 
proportions of both CD4 +DR + and CDS' DR + T-cell pop-
ulations whereas lymphocytes recovered from peripheral 
blood express only CD8+DR+ activity. This also suggests 
that local events within the graft. particularly activation of 
the CD4 + DR + subset. are not fully reflected by changes 
seen in the peripheral blood. This is also the first report. in 
patients immunosuppressed with FK 506. to document an 
increase in DR - T cells with active rejection in pulmonary 
and cardiac transplant recipients. In renal transplantation. 
previous investigators using T lymphoc}1eS obtained from 
fresh kidney biopsies. have also documented an associa-
tion between CD3+DR+ or CD8+DR' subsets and the 
presence of acti·.e rejection 1.2 but this is the first study to 
demonstrate that activated CD4 + cells also accumulate 
during rejection episodes. 
Cytomegalovirus infections are also known to cause 
lymphocyte activation with expression of the DR+ marker 
resulting in nonspecific elevation of the CD8 + DR + T -ceil 
subset in the peripheral blood of renal~ transplant recipi, 
ents during both rejection and infection. Similar increases 
in PBL CDS + DR + T cells during infection were also seen 
in cardiac transplant recipients"·5 although the association 
with rejection was less clear. In this study. 2 episodes of 
active obliterative bronchiolitis, accompanied by CMV 
pneumonitis. were associated with the largest increases in 
PBL CDS +DR + T cells. Of interest is that values obtainerl 
from BAL lymphocytes. at the site of infection. were only 
intermediary within the range of values from rejection 
episodes. The proportion of CD4 + DR + T lymphocytes in 
either PBL or BAL did not appear to be affected by the 
presence of CMV. These studies support our observation 
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that use of peripheral blood T lymphocytes may not be 
sufficient to distinguish rejection from CMY infection and 
that analysis of graft-infiltrating cells more accurately 
reflects intragraft events. 
The results from this study suggest that analysis of DR + 
subsets of T cells, particularly CD8 + DR +, may be helpful 
in the routine monitoring of thoracic transplant recipients 
in that significant changes occur coincident with the his-
tologic diagnosis of active rejection. Analysis of subpop-
ulations of BAL lymphoc~les shows that proportions of 
DR + cells greater than 4()q are always associated with 
active rejection whether acute or chronic. Elevations in 
the CD8 + DR + subset of PBL lymphocytes indicates a 
probability of active rejectiun or CMY infection which, in 
pulmonary transplant recipients, would lead to further 
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testing to obtain a diagnosis. Whether these tests will be . 
useful as a screening tool for rejection is the subject of 
ongoing investigation. 
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